Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Stanford Researchers Develop Breakthrough Liquid Biopsy for Cancer Resistance and Tissue Injury
Researchers at Stanford Medicine have developed a new blood test that can detect cancers, identify treatment resistance, and monitor tissue damage caused by non-cancerous conditions. The test works by analysing fragments of RNA found circulating in the bloodstream, known as cell-free RNA (cfRNA)....
Alpha Cognition Launches Breakthrough ZUNVEYL for Mild to Moderate Alzheimer’s
Alpha Cognition, a biopharmaceutical company focused on neurodegenerative diseases, has officially launched ZUNVEYL, a new treatment for individuals with mild to moderate Alzheimer’s disease. ...
Imfinzi Approved in EU as First Immunotherapy for Limited-Stage SCLC
AstraZeneca's Imfinzi (durvalumab) has received approval in the European Union (EU) for use as a monotherapy in adults with limited-stage small cell lung cancer (LS-SCLC). The treatment is specifically for patients whose...
Olverembatinib Receives Breakthrough Therapy Designation for Treating Philadelphia Chromosome-Positive (Ph+) ALL
Olverembatinib has been granted Breakthrough Therapy Designation (BTD) by China’s National Medical Products Administration (NMPA) through the Centre for Drug Evaluation (CDE). ...
The University of Texas MD Anderson Cancer Center Develops Novel Antibody-Toxin Conjugate
Researchers at The University of Texas MD Anderson Cancer Center have developed an innovative antibody-toxin conjugate (ATC) designed to stimulate the immune system to eliminate tumours. This new approach combines the advantages of both antibody-drug conjugates...
FDA Grants Breakthrough Therapy Designation for Petosemtamab in 1L PD-L1+ Head and Neck Cancer
Merus N.V has announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for petosemtamab in combination with pembrolizumab. This designation applies to the first-line treatment of adult patients with recurrent or metastatic programmed...
Inhalon Biopharma Introduces First-of-its-Kind Inhaled Antibody Therapy for RSV Advancing to Human Trials
Inhalon Biopharma focused on inhaled antibody therapies for acute respiratory infections (ARI), has completed studies required to support an investigational new drug (IND) application for its respiratory syncytial virus (RSV) candidate, IN-002. ...
University of Toronto and Insilico Medicine Announce Breakthrough in Quantum AI for Drug Discovery
A recent study led by researchers from the University of Toronto and Insilico Medicine has demonstrated the potential of quantum computing and artificial intelligence (AI) in transforming the drug discovery process. ...
UCLA Health Advances Breakthrough Targeted Therapies for Breast Cancer
Targeted therapies are transforming the treatment of breast cancer, leading to significant improvements in both survival rates and patients' quality of life. ...
Bluejay Therapeutics Receives FDA Breakthrough Designation for Chronic Hepatitis Delta
Bluejay Therapeutics, a clinical-stage biopharmaceutical company focused on developing potential treatments for serious viral and liver diseases, has announced that its lead product candidate, brelovitug (also known as BJT-778)...
